Renal Cell Carcinoma (RCC) Clinical Roundup
(City of Hope) July 22, 2020 - Experts at City of Hope and the Translational Genomics Research Institute (TGen) are using one of the world’s most comprehensive genomic analysis tools to map out personalized treatment plans for metastatic kidney cancer patients.
(NCI/Cancer Currents Blog) July 23, 2020 - A test that analyzes DNA in blood accurately identified two kinds of cancer, according to two new studies.
(Exelixis) July 20, 2020 - Exelixis, Inc. today announced the initiation of CONTACT-03, a global phase 3 pivotal trial of cabozantinib (CABOMETYX®) in combination with atezolizumab (TECENTRIQ®) in patients with inoperable, locally advanced or metastatic renal cell carcinoma (RCC) who progressed during or following treatment with an...
(Cancer) - 2020-07-17
(Clinical cancer research : an official journal of the American Association for Cancer Research) - 2020-06-18
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology) - 2020-06-04
(ESMO open) - 2020-07-17